For the millions who suffer from Gastroesophageal Reflux Disease (GERD), a study published today in the New England Journal of Medicine (NEJM) provides clinical evidence of safety and effectiveness for a new, FDA-approved medical device. Torax Medical’s LINX® Reflux Management System was studied in a controlled, prospective, multicenter trial involving 14 U.S. and European medical centers as part of the FDA pre-market approval process. The patients were evaluated before and after treatment to determine the effect of the LINX System on their GERD using pre-defined success criteria, which included reduction of esophageal acid, improvement in quality of life and elimination of reflux medications.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60077-torax-medical-linx-reflux-management-system-clinical-study-published
According to a national study released today, moms are feeling overwhelming pressure to overspend on products for their babies even as they significantly cut back in nearly every other area of their lives to cope with these challenging times.
To view Multimedia News Release, go to http://www.multivu.com/mnr/54418-kelton-research-mom-study-baby-products-store-brand-infant-formula
Findings from continued clinical studies of investigational chimeric antigen receptor (CAR) therapy, CTL019, demonstrate its potential role in the treatment of certain types of lymphocytic leukemia. In one long-term study of pediatric patients with acute lymphoblastic leukemia (ALL), results showed that 36 of 39 pediatric patients with relapsed/refractory (r/r) ALL, or 92%, experienced complete remissions (CR) with CTL0191.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7393851-novartis-new-ctl019-clinic-data-acute-lymphoblastic-leukemia/
Abila, the leading provider of software and services to nonprofits, associations, and government entities, today announced findings from its Donor Loyalty Study: A Deep Dive into Donor Behaviors and Attitudes. The study is an extension of Abila’s Donor Engagement Study from 2015, and provides a much more detailed look at specific attitudes and behaviors of donors; type, length, and frequency of content that resonates with donors; the importance of personalization; and how donors view the use of donated dollars.
The study also includes insights across four generations (Millennials, Generation Xers, Boomers, and Matures), as well as a special section on high-wealth donors (those who make more than $200,000 annually).
To view the multimedia release go to:
http://www.multivu.com/players/English/7802151-abila-donor-loyalty-study/
Results from the global Diabetes Attitudes, Wishes and Needs 2 study (DAWN2™) presented today at a symposium during the World Diabetes Congress of the International Diabetes Federation (IDF), show that only 29% of people with diabetes report that their healthcare team ask for their input when making their treatment plans. Furthermore, only 33% said they were encouraged by their healthcare professional to ask questions in the consultation.
To view Multimedia News Release, go to http://www.multivu.com/mnr/64152-novo-nordisk-diabetes-report-doctor-treatment
Launching today, the Safe Firearms Storage campaign encourages firearms owners to make safe firearms storage a priority. According to a study by the RAND Corporation using statistics from the United States Centers for Disease Control and Prevention, approximately 1.4 million homes have firearms stored in a way that makes them accessible to the wrong hands – children, at–risk youth, potential thieves, and those who intend to harm themselves or others.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/7111651-national-crime-prevention-council-family-firearms-safety-campaign
The most detailed analysis yet of the role germline mutations in genes associated with cancer predisposition play in the development of childhood cancer suggests that comprehensive genomic screening may be warranted on all pediatric cancer patients, not just those with a family history of cancer. The study from the St. Jude Children’s Research Hospital – Washington University Pediatric Cancer Genome Project appears in the November 19 edition of the New England Journal of Medicine.
Ultimately, researchers anticipate that systematic monitoring of patients and family members who have germline mutations in cancer predisposition genes will allow the detection of cancers at their earliest and most curable stage, thereby improving the outcomes for these children and family members.
To view the multimedia release go to:
http://www.multivu.com/players/English/7692851-st-jude-hospital-genome-project/
A recent study found that only 47% of Americans are currently taking steps to prevent bone loss1, despite considering it to be of high importance. In an effort to educate the public about the importance of bone health, Sunsweet Growers has partnered with the International Osteoporosis Foundation (IOF) to support their annual World Osteoporosis Day (WOD) campaign. WOD is globally celebrated on October 20 and serves to create awareness for bone health and the steps that can be taken to protect bones including incorporating bone-building habits – like eating prunes – into a regular lifestyle routine.
Bones need the right nutrients to stay strong and healthy and research suggests that eating just 5-6 prunes (the Feel Good Fruit!) each day may help to prevent bone loss. However, many do not think about bone health until after a fracture or break occurs.
To view the multimedia release go to:
https://www.multivu.com/players/English/8410051-sunsweet-iof-world-osteoporosis-day-bone-health/
New findings from an oral health study conducted earlier this year by United Concordia Dental and Highmark Inc. show pharmacy costs can average $1,477 lower per year for diabetics who have gum disease and receive at least seven treatments or visits to treat the disease.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58161-highmark-united-concordia-dental-gum-disease-pharmacy-costs-diabetes
Today the District of Columbia Department of Health (DOH) released a new report, “DC Takes On HIV: Public Awareness, Resident Engagement and a Call to Action,” which details the results of an extensive survey of residents’ awareness, knowledge, and behavior associated with the city’s five-year social marketing campaign for HIV prevention.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7379651-dc-department-of-health-study-shows-dc-takes-on-hiv-campaign-effective/
A study conducted by researchers from the University of L’Aquila in Italy and Mars, Incorporated provides compelling new evidence that the regular consumption of dietary cocoa flavanols may improve cognitive function in elderly subjects with early memory decline. Just published online in the journal Hypertension, this current study significantly advances understanding of the benefits of flavanols by specifically exploring the impact of regular cocoa flavanol consumption on cognitive function in a population with Mild Cognitive Impairment (MCI). Previous research has suggested that the benefits of cocoa flavanols could extend to the brain. However, these studies were either only short-term or did not demonstrate a consistent cognitive benefit. This unique study addresses this gap and provides important insights into the possibility of slowing or even reversing cognitive declines associated with aging through consumption of these natural compounds.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/prne/marsincorporated/56580/
Raptor Pharmaceutical Corp. (“Raptor” or the “Company”) (Nasdaq: RPTP), today announced that the U.S. Food and Drug Administration (FDA) has approved PROCYSBI™ (cysteamine bitartrate) delayed release capsules for the treatment of nephropathic cystinosis in adults and children 6 years and older. In a Phase 3 study, PROCYSBI showed consistent cystine depletion over the full 12-hour dosing period. Sustained levels of cysteamine have not historically been achieved in the majority of patients in this population. Studies have shown that sustained cystine depletion in patients may significantly delay disease progression, including kidney dysfunction, dialysis, kidney transplant, organ failure and premature death.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61338-raptor-pharmaceutical-procysbi-fda-approval-nephropathic-cystinosis
